 1MG was actually started in 2015 and before that actually it was a line in my previous business, HealthCart. I started HealthCart in 2011. So 1MG started with a simple idea that consumers need transparency in their healthcare. So we first created actually a content platform around medicines like a database of Wikipedia of medicine information and that became India's largest health app. Just people used to come to read about their medicines and compare prices between various brands and all of that. What we thought was that we need to go beyond just information and transparency and we wanted to make healthcare understandable, accessible and affordable. So that's when we added the transaction layers that can be provide medicines, lab tests, consultations also on an integrated platform. So we started building those transaction lines of business. So in fact the users only started asking us that they are getting all their medicine information on 1MG. Why can't they buy? So we started connecting them with local pharmacies and that's how the business started scaling up. Then we added diagnostics then consultations. I think there's a lot of misinformation around this. Now last year in August the government had come up with draft pharmacy notification. After that a lot of the vested interests associations and all went to various courts trying to get a stay based on some misinformation and initially there was an order that said that all players who are operating without license should be banned. Now we also agree with that actually. It doesn't impact us because all the transactions that go through our platform everything goes from a licensed premise on only. So the one the understanding of that verdict itself was not very it was I would say interpreted in different ways by different people and then the association tried to spread some misinformation. The court cases are still on so a matter is anyway substituted. We believe our model is perfectly in compliance. So there is actually no stoppage of operation given that every single dispensation happens from a licensed premises. I think the challenge is that this space needs a lot more investment and a lot of innovation and a lot of entrepreneurs started with various parts of the health care business and e-farmacy is an is very important like whatever part of health care you do need medicines also as a part of it. So a lot of entrepreneurs in health care actually gave up and they started and then they shut their operation for one of two reasons one because the regulatory pressure they felt was too much and secondly because the investors would always be concerned whether the regulator is going to be supportive or not. So a lot of these issues I think are true for most regulated sectors. They are designed to make innovators feel a little challenged. So now as a result of it a lot of entrepreneurs in health care have given up already and that's not a good sign because there's so much more that needs to be done. The building block of that is we need to have very clear norms for e-farmacy. We need to have very clear norms for something like telemedicine. So while telemedicine is another one topic where the prime minister has also spoken of providing doctors through technology in distant villages and all but again it's in the same grey zone. So I think some of these things in regulated industries are important to be clarified with speed so that entrepreneurship can thrive. So I think one thing that is very very important is that one we have very very proactively engaged with the government from the beginning to make sure that our model does not break any law. We are in full compliance and investors need that. Having said that it's it's not been an easy process to raise investment in this space. It's only because see if all the investors what are they looking for? They are looking for large industries with a lot of pain points which technology can solve. This industry can solve all of that. It has all those characteristics. The only I would say overhang has been what will be the regulatory impact and for us it took a lot of effort to convince investors that we are in full compliance.